Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.
about
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesMyocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease.Anabolic agents for improving muscle regeneration and function after injury.Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats.Experimental Evidences Supporting the Benefits of Exercise Training in Heart Failure.
P2860
Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cardiac implications for the u ...... management of muscle wasting.
@ast
Cardiac implications for the u ...... management of muscle wasting.
@en
type
label
Cardiac implications for the u ...... management of muscle wasting.
@ast
Cardiac implications for the u ...... management of muscle wasting.
@en
prefLabel
Cardiac implications for the u ...... management of muscle wasting.
@ast
Cardiac implications for the u ...... management of muscle wasting.
@en
P2860
P356
P1476
Cardiac implications for the u ...... e management of muscle wasting
@en
P2093
Peter Molenaar
P2860
P304
P356
10.1038/SJ.BJP.0706670
P407
P577
2006-03-01T00:00:00Z